Interv Akut Kardiol. 2017;16(2):80-83 | DOI: 10.36290/kar.2017.012

Reverted sudden death and malignant arrhythmias in the patient after myocarditis

Adel Abdulghani1, 2, Jozef Jakabčin2, Milouš Derner3, Pavel Červinka2
1Městská nemocnice Duchcov, 2Klinika kardiologie, Krajská zdravotní, a.s., Ústí nad Labem, 3RDG oddělení, Krajská zdravotní, a.s., Ústí nad Labem

The case report documents young man with myocarditis as a etiology of irreversible left ventricular dysfunction. Myocarditis is

the pathological result of myocardial infection and autoimmunity that causes active inflammatory destruction of myocytes. In

our case fibrotic scar tissue was documented with magnetic resonance imaging in the left ventricle and interventricular septal

tissue. Malignant arrhythmia was the etiology of aborted sudden cardiac death in the acute phase and few months later. Case

describes the process of differential diagnosis of acute phase after ventricular tachycardia at the emergency department. Prognosis

of patients after myocarditis is not easy to estimate. In this case the patient's prognosis is relatively better due to implantation of

the cardioverter defibrillator device and exclusion of the fulminant progression of the heart failure.

Keywords: myocarditis, sudden cardiac death, magnetic resonance, cardioverter defibrillator

Received: April 18, 2017; Accepted: May 16, 2017; Published: May 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Abdulghani A, Jakabčin J, Derner M, Červinka P. Reverted sudden death and malignant arrhythmias in the patient after myocarditis. Interv Akut Kardiol. 2017;16(2):80-83. doi: 10.36290/kar.2017.012.
Download citation

References

  1. Fabre A, Sheppard MN. Sudden adult death syndrome and other non ischaemic causes of sudden cardiac death: a UK experience. Heart. 2006; 92(3): 316-320. Go to original source... Go to PubMed...
  2. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust. 2004; 180: 110-112. Go to original source... Go to PubMed...
  3. Priori S G, a kol. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015; 36: 2793-2867. Go to original source... Go to PubMed...
  4. Felker GM, a kol. The spectrum of dilated cardiomyopathy: the Johns Hopkins experience with 1,278 patients. Medicine (Baltimore). 1999; 78: 270-283. Go to original source... Go to PubMed...
  5. Mahrholdt H, a kol. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109: 1250-1258. Go to original source... Go to PubMed...
  6. Lieberman EB, a kol. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991; 18: 1617-1626. Go to original source... Go to PubMed...
  7. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006; 113(6): 876-890. Go to original source... Go to PubMed...
  8. Ponikowski P, a kol. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016; 37: 2129-2200. Go to original source... Go to PubMed...
  9. Calforio, a kol. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; Sep 34(33): 2636-2648. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.